Additionally, the company plans to collaborate with Labcorp to expand the market coverage of the ColoSense® test, integrating it into comprehensive screening programs offered by healthcare providers. Summary The dynamics in the capital markets of the biopharmaceutical sector in 2025 reveal several ...